Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 734-746

  Kimmel, Heather L ^a   Holtzman, Stephen G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; LEVORPHANOL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALTREXONE; OPIATE AGONIST; PETHIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MOVEMENT; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; LOCOMOTION; MICRODIALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SUBSTANTIA NIGRA;

AMPHETAMINE; ANIMALS; COCAINE; DRUG SYNERGISM; MALE; MOTOR ACTIVITY; NALTREXONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 0030755477     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. ADAMS, P. M., BEAUCHAMP, R. AND ALSTON, C.: Potentiation of apomorphine and d-amphetamine effects by naloxone. Life Sci. 28: 629-634, 1981.
2. ANDREWS, J. S. AND HOLTZMAN, S. G.: Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats. Neuropharmacolqgy 26: 1115-1120, 1978.
3. ARBUTHNOTT, G. W., FAIRBROTHER, I. S. AND BUTCHER, S. P.: Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. Pharmacol. Ther. 48: 281-293, 1991.
4. BILSKY, E. J., MONTEGUT, M. J., DELONG, C. L. AND REID, L. D.: Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50: PL-85-PL-90, 1992.
5. BLUNDELL, C., CROSSMAN, A. B. AND SLATER, P.: The effect of morphine on turning behaviour in rats and mice with unilateral 6-hydroxydopamine lesions. Br. J. Pharmacol. 456P, 1976.
6. BROADBENT, J., GASPARD, T. M. AND DWORKIN, S. I.: Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids. Pharmacol. Biochem. Behav. 51: 379-385, 1995.
7. BROWN, E. E., FINLAY, J. M., WONG, J. T. F., DAMSMA, G. AND FIBIGER, H. C.: Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J. Pharmacol. Exp. Ther. 256: 119-126, 1991.
8. CARROLL, M. E. AND LAC, S. T.: Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 106: 439-446, 1992.
9. CORRIGALL, W. A. AND COEN, K. M.: Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104: 167-170, 1991.
10. COWAN, A., DETTMAR, P. W. AND WALTER, D. S.: Analgesics and rotational behaviour in rats with unilateral substantia nigra lesions. Effects in the presence and absence of (+)-amphetamine. Br. J. Pharmacol. 316P, 1975.
11. COWAN, A., LEWIS, J. W. AND MACFARLANE, I. R.: Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br. J. Pharmacol 60: 537-545, 1977.
12. DETTMAR, P. W., COWAN, A. AND WALTER, D. S.: Naloxone antagonizes behavioral effects of d-amphetamine in mice and rats. Neuropharmacology 17: 1041-1044, 1978.
13. DI CHIARA, G. AND IMPERATO, A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85: 5274-5278, 1988a.
14. DI CHIARA, G. AND IMPERATO, A.: Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244: 1067-1080, 1988b.
15. DYKSTRA, L. A., DOTY, P., JOHNSON, A. B. AND PICKER, M. J.: Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend. 30: 227-234, 1992.
16. FOLTIN, R. W. AND FISCHMAN, M. W.: Effects of buprenorphine on the self-administration of cocaine by humans. Behav. Pharmacol. 5: 79-89, 1994.
17. GATCH, M. B., NEGUS, S. S., BUTELMAN, E. R. AND MELLO, N. K.: Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys. J. Pharmacol. Exp. Ther. 275: 1346-1354, 1995.
18. GERRITS, M. A. F. M., PATKIMA, N., ZVARTAU, E. E. AND VAN REE, J. M.: Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology 119: 92-98, 1995.
19. GOODMAN, R. R., AIDER, B. A. AND PASTERNAK, G. W.: Regional distribution of opioid receptors. In The Opiate Receptors, ed. by G. W. Pasternak, pp. 197-228, The Humana Press, Clifton, NY, 1988.
20. HITZEMANN, R., CURRELL, J., HOM, D. AND LOH, H.: Effects of naloxone on d-amphetamine and apomorphine-induced behavior. Neuropharmacology 21: 1005-1011, 1982.
21. HOLTZMAN, S. G.: Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J. Pharmacol. Exp. Ther. 189: 51-60, 1974.
22. HOLTZMAN, S. G. AND LOCKE, K. W.: Neural mechanisms of drug stimuli: experimental approaches. In Transduction Mechanisms of Drug Stimuli, ed. by F. C. Colpaert and R. L. Balster, pp. 139-153, Springer-Verlag, Berlin, Heidelberg, 1988.
23. HOOKS, M. S., JONES, D. N. C., JUSTICE, J. B. J. AND HOLTZMAN, S. G.: Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 42: 765-770, 1992.
24. HUDSON, J. L., VAN HORNE, C. G., STROMBERG, I., BROCK, S., CLAYTON, J., MASSERANO, J., HOFFER, B. J. AND GERHARDT, G. A.: Correlation of apomorphine-and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Br. Res. 626: 167-174, 1993.
25. IWATSUBO, K. AND CLOUET, D. H.: Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons. J. Pharmacol. Exp. Ther. 202: 429-436, 1977.
26. JACKSON, H. C., GRIFFIN, I. J. AND NUTT, D. J.: Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behavior. J. Pharm. Pharmacol. 45: 636-640, 1993.
27. JAFFE, J. H. AND MARTIN, W. R.: Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, L. S. Goodman, T. W. Rall and F. Murad, pp. 491-531, MacMillan, New York, 1985.
28. JONES, D. N. C. AND HOLTZMAN, S. G.: Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J. Pharmacol. Exp. Ther. 262: 638-645, 1992.
29. JONES, D. N. C. AND HOLTZMAN, S. G.: Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacology 114: 215-224, 1994.
30. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Br. Res. Rev. 16: 223-244, 1991.
31. KAUPPILA, T., MECKE, E. AND PERTOVAARA, A.: Enhancement of morphine-induced analgesia and attenuation of morphine-induced side-effects by cocaine in rats. Pharmacol. Toxicol. 71: 173-178, 1992.
32. KIMMEL, H. L., GARRETT, B. E. AND HOLTZMAN, S. G.: Effects of acute and chronic morphine on rotational behavior in nigral-lesioned rats. Pharmacol. Biochem. Behav. 52: 397-401, 1995.
33. KOSTEN, T. A., MARBY, D. W. AND NESTLER, E. J.: Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment. Life Sci. 49: PL-201-PL206, 1991.
34. KOSTEN, T. R., GAWIN, F. H., ROUNSAVILE, B. J. AND KLEBER, H. D.: Cocaine abuse among opioid addicts: demographic features in treatment. Am. J. Drug Ther. 199: 649-661, 1986.
35. KOSTEN, T. R., KLEBER, H. D. AND MORGAN, C.: Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 44: 887-892, 1989.
36. KREEK, M. J.: Multiple drug abuse patterns and medical consequences. In Psychopharmacology: The Third Generation of Progress, ed. by H. Y. Meltzer, pp. 1597-1604, Raven Press, New York, 1987.
37. KUCZENSKI, R. AND SEGAL, D.: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9: 2051-2065, 1989.
38. LEANDER, J. D.: Buprenorphine has potent kappa opioid receptor antagonist activity. Neuropharmacology 26: 1445-1447, 1987.
39. LONGONI, R., SPINA, L. AND DI CHIARA, G.: Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility. Psychopharmacology 93: 401-402, 1987.
40. LYNCH, M. R. AND CAREY, R. J.: Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical organization. Behav. Brain Res. 32: 69-74, 1989.
41. MANSOUR, A., Fox, C. A., AKIL, H. AND WATSON, S. J.: Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18: 22-29, 1995.
42. MATTHEWS, R. T. AND GERMAN, D. C.: Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neurosci. 11: 617-625, 1984.
43. MELLO, N. K., LUKAS, S. E., KAMIEN, J. B., MENDELSON, J. H., DRIEZE, J. AND CONE, E. J.: The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 260: 1185-1193, 1992.
44. MELLO, N. K., LUKAS, S. E., MENDELSON, J. H. AND DRIEZE, J.: Naltrexonebuprenorphine interactions: effects on cocaine self-administration. Neuropsychopharmacology 9: 211-224, 1993.
45. MELLO, N. K., NEGUS, S. S., LUKAS, S. E., MENDELSON, J. H., SHOLAR, J. W. AND DRIEZE, J.: A primate model of polydrug abuse: cocaine and heroin combinations. J. Pharmacol. Exp. Ther. 274: 1325-1337, 1995.
46. MURRAY, T. F. AND LEID, M. E.: Interaction of dextrorotary opioids with phencyclidine recognition sites in rat brain membranes. Life Sci. 34: 1899-1911, 1984.
47. NEGUS, S. S. AND DYKSTRA, L. A.: K-Antagonist properties of buprenorphine in the shock titration procedure. Eur. J. Pharmacol. 156: 77-86, 1988.
48. NEGUS, S. S., PICKER, M. J. AND DYKSTRA, L. A.: Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology 102: 465-473, 1990.
49. OLIVERIO, A. AND CASTELLANO, C.: Genotype-sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse. Psychopharmacologia 39: 13-22, 1974.
50. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1986.
51. PERT, A.: The effects of opiates on nigrostriatal dopaminergic activity. In Characteristics and Functions of Opioids, ed. by J. M. van Ree and L. Terenius, pp. 389-401, Elsevier/North-Holland Biomedical Press, New York, 1978.
52. RAMSEY, N. F. AND VAN REE, J. M.: Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 40: 807-810, 1991.
53. RETHY, C. R., SMITH, C. B. AND VILLARREAL, J. E.: Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse. J. Pharmacol. Exp. Ther. 176: 472-479, 1971.
54. SALA, M., BRAIDA, D., COLUMBO, M., GROPPETTI, A., SACCO, S., GORI, E. AND PARENTI, M.: Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J. Pharmacol. Exp. Ther. 274: 450-457, 1995.
55. SCHAD, C. A., JUSTICE, J. B. JR. AND HOLTZMAN, S. G.: Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. Eur. J. Pharmacol. 275: 9-16, 1995.
56. SHARIF, N. A. AND HUGHES, J.: Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10: 499-522, 1989.
57. SHIPPENBERG, T. S., BALS-KUBIK, R. AND HERZ, A.: Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265: 53-59, 1993.
58. SIERRA, V., DUTTAROY, A., LUFTY, K., CANDIDO, J., BILLINGS, B., ZITO, S. W. AND YOBURN, B. C.: Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci. 50: 591-597, 1992.
59. SPANAGEL, R., HERZ, A. AND SHIPPENBERG, T. S.: Identification of the opioid receptor types mediating β-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 190: 177-184, 1990.
60. SPEALMAN, R. D. AND BERGMAN, J.: Modulation of the discriminative-stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther. 261: 607-615, 1992.
61. SPEALMAN, R. D. AND BERGMAN, J.: Opioid modulation of the discriminative stimulus effect of cocaine: comparison of μ, κ and δ agonists in squirrel monkeys discriminating low doses of cocaine. Behav. Pharmacol. 5: 21-31, 1994.
62. SUN, F.-Y., ZHU, H., ZHANG, L.-M., Xu, X.-R. AND ZHANG, A.-Z.: Dextrorphan: an antagonist for phencyclidine receptor. NIDA Res. Monogr. 75: 169-172, 1986.
63. SUZUKI, T., SHIOZAKI, Y., MASUKAWA, Y., MISAWA, M. AND NAGASE, H.: The role of mu-and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn. J. Pharmacol. 58: 435-442, 1992.
64. TRUJILLO, K. A., BELLUZZI, J. D. AND STEIN, L.: Naloxone blockade of amphetamine place preference conditioning. Psychopharmacology 104: 265-274, 1991.
65. UNGERSTEDT, U.: Postsynaptic supersensitivity after 6-hydroxydopamine induced denervation of the nigro-striatal dopamine system. Acta. Physiol. Scand. 82: 69-93, 1971.
66. UNGERSTEDT, U. AND ARBUTHNOTT, G. W.: Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine behaviour system. Br. Res. 24: 485-493, 1970.
67. WINSLOW, J. T. AND MICZEK, K. A.: Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys. Psychopharmacology 96: 493-499, 1988.
68. WOOD, P. L.: Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides 4: 595-601, 1983.
69. WOOD, P. L. AND IYENGAR, S.: Central actions of opiates and opioid peptides: In vivo evidence for opioid receptor multiplicity, In The Opiate Receptors, ed. by G. W. Pasternak, pp. 307-356, The Humana Press, Clifton, NY, 1988.
70. WOOLVERTON, W. L.: Analysis of drug interactions in behavioral pharmacology. In Neurobehavioral Pharmacology, ed. by T. Thompson, P. B. Dews and J. E. Barrett, pp. 275-302, Lawrence Erlbaum Associates, Hillsdale, NJ, 1987.
71. ZETTERSTROM, T., HERRERA-MARSCHITZ, M. AND UNGERSTEDT, U.: Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxy-dopamine denervated rats using intracerebral dialysis. Br. Res. 376: 1-7, 1986a.
72. ZETTERSTROM, T., SHARP, T. AND UNGERSTEDT, U.: Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur. J. Pharmacol. 132: 1-9, 1986b.